SCHEMBL7845976

SCHEMBL7845976

CNCCCN(C)c1ccc(Nc2cc(NC(=O)c3ccnc(N4CCOCC4)c3)ccc2C)c(C)c1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4827725 0.87 MAPK14 (0.55) MAPK14
SCHEMBL4831618 0.85 MAPK14 (0.54) MAPK14
SCHEMBL4829504 0.80 MAPK14 (0.61) MAPK14
SCHEMBL4824342 0.79 MAPK14 (0.52) MAPK14
SCHEMBL5897231 0.79 MAPK14 (0.68) MAPK14
SCHEMBL7594290 0.79 MAPK14 (0.77) MAPK14
SCHEMBL4831641 0.78 MAPK14 (0.60) MAPK14
SCHEMBL5897115 0.77 MAPK14 (0.65) MAPK14
SCHEMBL7841389 0.76 MAPK14 (0.71) MAPK14
SCHEMBL5897121 0.76 MAPK14 (0.62) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115707-A1 BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS AstraZeneca AB (SE) 2001-07-18 EP disclosed
WO-2000018738-A1 BENZAMIDE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2000-04-06 WO disclosed